Yusuf Erkul is the founder of Kernal Biologics. Kernal Biologics has raised $36M in total funding. Latest round: Series A. Based in Cambridge, USA.
Yusuf Erkul is the co-founder and CEO of Kernal Biologics, a Cambridge, MA-based biotech company. Established in 2016, the company develops next-generation messenger RNA (mRNA) immunotherapies for cancer treatment. Erkul leads the company's work on a proprietary mRNA technology platform applied to oncology therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library